Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

75.0%

3 terminated/withdrawn out of 4 trials

Success Rate

25.0%

-61.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02179476Not ApplicableTerminated

A Multi-Site Study of the Zyga GlyDer Facet Restoration Device In Subjects With LUmbar FacET Pain Syndrome - DUET

Role: lead

NCT02560714Terminated

SI Joint Fusion and Decortication Using the SImmetry System

Role: lead

NCT02425631Completed

CT Follow-Up of the SImmetry Sacroiliac Joint Fusion System

Role: lead

NCT02064322Terminated

SAIF: Sacroiliac Fusion Study

Role: lead

All 4 trials loaded